IRCT20150124020765N2 IRCT 2019-01-06 Ahvaz University of Medical Sciences Effect of combined dietary weight loss and cranberry supplementation on Non-alcoholic fatty liver disease Effect of combined dietary weight loss and cranberry supplementation on hepatic enzymes, steatosis and inflammatory, antioxidant and apoptosis biomarkers in patients with Non-alcoholic fatty liver disease 2019-01-05 anticipated 50 Complete https://irct.ir/trial/36005 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this study; we assume equal allocation of subjects to each group With blocked randomization. With a randomized block design, the experimenter divides subjects in to subgroups called blocks, such that the variability within blocks is less than the variability between blocks. Then, subjects within each block are randomly assigned to treatment conditions, Blinding description: The researchers blind to the type of supplement given to each patient. A third party keep the identities of the subjects and which group (cranberry or placebo) they belong to, which are not revealed to researchers until the end of study. 3 Non-alcoholic fatty liver disease. Intervention 1: Intervention group: dietary weight loss and 2 capsules containing 288 mg Cranberry extract for 12 weeks. Intervention 2: Control group: dietary weight loss and 2 placebo capsules for 12 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No decision yet